Analytical Profile: Avenier a.s.
Key data on tenders won by this company, activity trends, and recent successes.
Tenders Won (12m)
38
Total Won Value (12m)
€45.3M
Average Contract Won
€1.2M
Top Category Won
Medical equipments, pharmaceuticals and personal care products
Avenier a.s. is a company actively participating in and winning public tenders. We present an analytical overview of their wins and contract values over the past 12 months.
According to our data, this company has won 38 tenders in the last year, with a total estimated value of €45.3M. The average contract value during this period was €1.2M, providing insight into the typical size of their successful bids.
Public Data vs. Professional Intelligence
You are viewing a free, public snapshot of this company's activity. The tend.ee Professional plan unlocks real-time data, predictive analytics, and our full AI-powered competitive analysis for this and thousands of other companies.
Recent Tenders (Sample)
| Date | Title | Status | Value (EUR) |
|---|---|---|---|
| 2025-12-19 | Czechia – Vaccines – LP s obsahem citalopramu I.V. forma; Očkovací látky 2025 | Tender Result | €19K |
| 2025-12-18 | Czechia – Pharmaceutical products – DYNAMICKÝ NÁKUPNÍ SYSTÉM NA DODÁVKY LÉČIVÝCH PŘÍPRAVKŮ, VÝŽIV A VYBRANÝCH ZDRAVOTNICKÝCH PROSTŘEDKŮ | Tender Result | €23K |
| 2025-12-12 | Czechia – Immune sera and immunoglobulins – Léčivé přípravky s obsahem nirsevimabu | Tender Result | €464K |
| 2025-12-09 | Czechia – Vaccines – Dodávka očkovacích látek pro mimořádné a zvláštní očkování fyzických osob a pro pravidelné očkování fyzických osob, které nejsou pojištěnci podle zákona upravujícího veřejné zdravotní pojištění, na roky 2026 – 2027 | Tender Result | €3.4M |
| 2025-12-05 | Czechia – Medicinal products for the musculo-skeletal system – Dodávky léků – Léčivá látka nusinersen – ATC M09AX07 | Tender Result | €12.8M |
Analyze with tend.ee AI Co-pilot
Consult your personalized AI Co-pilot on your winning strategy.
Access all 38 tenders from this category.
Get real-time alerts for new opportunities.
Analyze historical winners and competitors.
No card required. Limited-time offer with basic personalization.